Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis, +7

Journal of Clinical Oncology

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Armando Santoro, T Türsz, Henning T. Mouridsen, +7

Journal of Clinical Oncology

European Code Against Cancer and scientific justification: third version (2003)

Peter Boyle, Philippe Autier, Harry Bartelink, +38

Annals of Oncology

OncologyCancer EpidemiologyScientific JustificationGlobal HealthBioethics +7

Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

Axel Le Cesne, Ian Judson, D. Crowther, +10

Journal of Clinical Oncology

Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience

Antonio Llombart‐Cussac, Xavier Pivot, G Contesso, +5

British Journal of Cancer

Surgical OncologyOncologyAdjuvant ChemotherapyCancer TreatmentMedicine +1

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

William P. Steward, Jaap Verweij, R. Somers, +7

Journal of Clinical Oncology

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

Q G van Hoesel, Jaap Verweij, G. Catimel, +7

Annals of Oncology

Surgical OncologyMalignant DiseaseMedicineMetronomic TherapyPathology +4

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

Karim Fizazi, Nadine Dohollou, Jean‐Yves Blay, +6

Journal of Clinical Oncology

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

OS Nielsen, P Dombernowsky, H.T. Mouridsen, +8

British Journal of Cancer

Surgical OncologyOncologyBone Sarcoma GroupMetronomic TherapyHigh-dose Epirubicin +6

Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.

Abdelmajid Zyad, Jean Bénard, T Türsz, +1

PubMed

Tumor BiologyBreast OncologyTnf ResistanceMedicineImmunology +12